Mckenna competitive analysis

Explore patent oppositions filed by Mckenna against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Real Time Monitoring Of Product PurificationBOEHRINGER INGELHEIM RCV GMBH & CO KGAug 5, 2026
Modulation Of Ube3A-Ats ExpressionBAYLOR COLLEGE OF MEDICINEApr 16, 2025
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKJun 13, 2024
Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)FRED HUTCHINSON CANCER CENTEROct 12, 2022
Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 14, 2022
Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALSAug 6, 2020
Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L1VENTANA MEDICAL SYSTEMSOct 9, 2019
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKSep 26, 2019
Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3VENTANA MEDICAL SYSTEMSJul 10, 2019

Latest PTAB cases involving Mckenna

Discover the latest PTAB cases involving Mckenna, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 27, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Mckenna

IPR2018-00717Feb 28, 2018KASHIV PHARMAMCKENNATerminated-Settled
IPR2018-00625Feb 27, 2018KASHIV PHARMAMCKENNATerminated-Settled

Peer Comparison New

IP litigation analysis comparing Mckenna with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CMS CAMERON MCKENNA NABARRO OLSWANG12 - - -
NOVO NORDISK912719
SALIX PHARMACEUTICALS - 19 - 3
VENTANA MEDICAL SYSTEMS - 3 - -